TCT 22: Patent Foramen Ovale Closure With the Occlutech Figulla Flex II Device: A Long-term (up to 10-years) Follow-up

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Terumo Medical Corporation; Amgen